Viewing Study NCT05421858

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:14 AM
Ignite Modification Date: 2026-06-26 @ 5:11 AM
Study NCT ID: NCT05421858
Status: RECRUITING
Last Update Posted: 2025-12-19
First Post: 2022-06-07
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.
Sponsor: Basilea Pharmaceutica
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Candidemia View
None Candidiasis, Invasive View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Fungal infection View
None Candida View
None Anti-fungal View
None Yeast View